Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Patent CN101481363B reveals a novel amidation route for repaglinide intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.
Novel microchannel nitration process for irinotecan intermediate ensures safety and yield. Supply chain reliability improved via intrinsic safety design and reduced waste discharge for global buyers.
Novel synthesis route for high-purity pharmaceutical intermediate offering safety and scale-up advantages for global supply chains and cost reduction.
Novel Wittig reaction route enhances purity and yield for gefarnate manufacturing, offering significant supply chain stability and cost reduction benefits for global pharmaceutical partners.
Novel 5-step synthesis of ent-chromazonarol from sclarealdehyde. Reduces steps vs prior art. Suitable for industrial scale-up and supply chain stability.
Patent CN101255171A reveals a safer carbapenem intermediate process eliminating toxic organotin. Achieve cost reduction and supply reliability.
Patent CN105399744B reveals optimized Omarigliptin synthesis. High yield and purity benefit supply chain stability and cost reduction significantly.
Novel efficient route for Xiawu Base B via C-H activation. Reduces cost and improves scalability for pharmaceutical manufacturing using accessible raw materials.
Patent CN105884728B details air-oxidized NHC catalysis for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN103012292A reveals a novel 2-step synthesis for dibenzo[b,f][1,2]diazocine, offering >50% yield and eliminating toxic mercury residues for reliable pharmaceutical intermediate supply.
Novel patent CN115504866B offers high-yield 4-methoxy-2-naphthol synthesis. Improves supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel crystallization method ensures 99.9% purity for Bilastine. Reduces impurities and enhances stability for reliable pharmaceutical supply chains.
Patent CN119039150A details a novel Negishi coupling route for high-purity Cobicistat intermediates, offering significant supply chain and cost advantages for manufacturers.
Patent CN116554054B reveals efficient styrene-based synthesis for ketoprofen and loxoprofen intermediates offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel two-step synthesis from styrene reduces cost and improves purity for pharmaceutical manufacturing supply chains.
Novel fragment condensation method for bivalirudin synthesis ensures high purity and yield. Reduces waste and cost for pharmaceutical intermediates manufacturing supply chain.
Patent CN113493405B reveals solid intermediate route for Milrinone. Enhances purity and safety for scalable pharmaceutical intermediate manufacturing supply chains.
Advanced catalytic hydrogenation and active anhydride acylation route for high-purity Tofacitinib Citrate, offering significant cost reduction and scalable manufacturing solutions.